Vulnerable myocardial interstitium in patients with isolated left ventricular hypertrophy and sudden cardiac death: a

Balaji K Tamarappoo1, Benjamin T John, Kyndaron Reinier

  • 1Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA (B.K.T., B.T.J., K.R., C.T., A.U.-E., S.S.C.) ; Cleveland Clinic Foundation, Cleveland OH (B.K.T.).

Insights

Sudden cardiac death in patients with isolated left ventricular hypertrophy (LVH) is linked to increased collagen volume and a higher proportion of type III collagen in the heart. These findings suggest a potential mechanism for increased arrhythmia vulnerability in LVH patients.

Area of Science:

  • Cardiology
  • Pathology
  • Biomedical Engineering

Background:

  • Concentric left ventricular hypertrophy (LVH) is a known risk factor for sudden cardiac death (SCD).
  • Alterations in the myocardial interstitium in animal models of LVH may increase susceptibility to ventricular arrhythmias.
  • Human studies are needed to evaluate these interstitial changes in LVH patients who experience SCD.

Purpose of the Study:

  • To investigate myocardial interstitial differences in patients with isolated LVH and SCD.
  • To compare collagen content, collagen subtypes, and gap junction alterations in LVH+SCD cases versus controls.
  • To identify potential structural factors contributing to SCD in LVH.

Main Methods:

  • Postmortem analysis of myocardial tissue from 12 LVH+SCD patients and 34 controls (18 with LVH, 16 with normal hearts).
  • Measurement of heart weight, collagen volume fraction, and collagen type III percentage.
  • Quantification of connexin 43-labeled gap junctions.

Main Results:

  • LVH+SCD cases had significantly higher normalized heart weight and collagen volume fraction compared to both control groups.
  • A significantly higher relative amount of type III collagen was observed in LVH+SCD cases.
  • Increased connexin 43-labeled gap junctions correlated with larger myocyte size.

Conclusions:

  • SCD in isolated LVH is associated with increased myocardial mass and overall collagen.
  • A relative abundance of type III collagen is a novel finding in LVH with SCD.
  • Further research is warranted to understand the mechanistic role of type III collagen in SCD associated with LVH.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...